Obio Technology (Shanghai) Corp., Ltd. (SHA:688238)
China
· Delayed Price · Currency is CNY 6.03
-0.19 (-3.05%)
At close: Jun 13, 2025, 2:57 PM CST
Obio Technology (Shanghai) Corp. Company Description
Obio Technology (Shanghai) Corp., Ltd., a biotechnology company, focuses on the development of gene therapy vectors in China.
The company provides gene function and gene therapy research, and other CRO services, such as drug target and drug efficacy research.
It also offers CDMO services, such as process development and testing, IND-CMC pharmaceutical research, and clinical sample GMP production for the research and development of genetic drugs.
The company was founded in 2013 and is headquartered in Shanghai, China.
Obio Technology (Shanghai) Corp., Ltd.
| Country | China |
| Founded | 2013 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 692 |
| CEO | Guodong Jia |
Contact Details
Address: Building 19 Shanghai, 201321 China | |
| Phone | 86 21 5858 5887 |
| Website | obiosh.com |
Stock Details
| Ticker Symbol | 688238 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| SIC Code | 8731 |
Key Executives
| Name | Position |
|---|---|
| Oudong Pan | Founder and Chairman of the Board |
| Guodong Jia Ph.D. | GM and Director |
| Luyuan Xu | Deputy GM, Chief Financial Officer and Board Secretary |
| Junyi Pan | Investment Director and Director |
| Fujie Wang | Vice President of Supply Chain and Information Technology and Director |
| Shan Yin | Deputy GM and Director |
| Qingmei Xia | Deputy General Manager |
| Xinglin Yang | R and D Director |
| Qinbin Wu | Chief Quality Officer |
| Jiali Yang | R&D Manager |